Ohmx
Private Company
Total funding raised: $3.5M
Overview
Ohmx is a Leuven-based omics service provider specializing in genomics, transcriptomics, epigenomics, proteomics, and single-cell sequencing for both research and clinical diagnostics. It differentiates itself through a strong focus on data quality (ISO-certified), a personalized client partnership model, and deep scientific expertise rooted in academia. The company serves pharmaceutical, biotech, and academic clients, offering end-to-end project management from experimental design to advanced bioinformatics.
Technology Platform
Multi-omics service platform centered on Oxford Nanopore long-read sequencing, complemented by short-read, single-cell, proteomics (mass spectrometry), and translatomics (ribosome profiling). Integrated with advanced bioinformatics and AI/ML for custom data analysis, all underpinned by an ISO-certified quality management system.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes with large, global CROs (e.g., Eurofins, Azenta), academic core facilities, and other specialized omics service providers. Differentiates through a strong focus on long-read sequencing applications, a partnership-oriented model, deep academic ties, and an emphasis on data quality and custom bioinformatics.